不孕症介入性临床试验的特征与未完成相关因素:ClinicalTrials.gov 数据库分析
该研究回顾分析 2010 至 2020 年注册于 ClinicalTrials.gov 的 505 项不孕症介入性临床试验,描述其干预类型、结局指标、入组人群与完成情况,并用逻辑回归评估申办方与试验地点对未完成的影响。结果显示药物干预最常见,活产作为结局的比例偏低,仅少数报告结果或种族信息,未完成多因招募不足;调整混杂后美国地点与未完成无显著关联。
要点
- 不孕症试验以药物干预为主,卵巢刺激试验占 27%。
- 仅 20% 试验追踪活产结局,15% 纳入男性受试者。
- 仅 11% 报告结果,4% 报告种族或族裔信息。
核心结论
- 不孕症试验主要研究药物干预,尤其卵巢刺激,活产结局追踪不足,试验应关注未被满足的需求并纳入弱势人群。
研究设计与样本
- 回顾性分析 2010 至 2020 年注册于 ClinicalTrials.gov 的 505 项不孕症介入性临床试验。
- 采用逻辑回归评估申办方与试验地点对试验未完成的影响。
主要发现
- 药物干预最常见(45%),卵巢刺激试验占 27%。
- 20% 的试验追踪活产结局,3% 包含心理健康结局。
- 15% 的试验纳入男性受试者,11% 报告结果,4% 报告种族或族裔信息。
- 82% 的试验在美国以外开展,18% 未完成,其中 47% 因招募不足。
- 单变量分析中美国试验未完成比值比为 2.48(95%CI [1.47, 4.17]),调整后为 0.95(95%CI [0.42, 2.14])。
临床怎么用
- 关注不孕症试验中活产结局的报告情况,评估其对临床决策的价值。
- 注意多数试验未报告结果与种族信息,解读证据时需考虑信息不完整。
- 试验设计应关注招募策略以减少因招募不足导致的未完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the interventional clinical trials in infertility and to assess whether trial location or industry sponsorship was associated with trial noncompletion. DESIGN: Retrospective review of trials registered with ClinicalTrials.gov. SETTING: None. PATIENT(S): None. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Descriptive statistics characterizing the attributes of the clinical trials including intervention type, topic, population, completion status, size, location, sponsor, and results. The effects of the sponsor and trial location on trial noncompletion were assessed via logistic regression. RESULT(S): In total, 505 trials initiated between 2010 and 2020 were included in our analysis. Drug interventions were the most commonly studied (45%); ovarian stimulation trials accounted for 27% of the studies. Live birth was tracked as an outcome by 20% of the studies; 3% of the trials included mental health outcomes. Few trials (15%) enrolled male participants. Only 11% of the trials reported results, and 4% of the trials reported the race or ethnicity of the participants. Most trials (82%) were conducted outside the United States. Overall, 18% of the trials were not completed, most often because of lack of accrual (47%). United States trials had over twice the odds of noncompletion in univariate analysis (odds ratio = 2.48, 95% confidence interval = [1.47, 4.17]); however, this relationship lost significance after adjusting for potential confounders (odds ratio = 0.95, 95% confidence interval = [0.42, 2.14]). Trial sponsorship was not associated with trial noncompletion. CONCLUSION(S): Infertility trials predominantly investigated drug interventions, particularly ovarian stimulation. Live birth was an infrequent outcome despite its relevance to patients. Clinical trials should aim to address the unmet needs in fertility care and be inclusive of underserved populations affected by infertility.
引用
- Peipert BJ, Spinosa D, Howell EP, et al. Innovations in infertility: a comprehensive analysis of the ClinicalTrials.gov database. Fertil Steril. 2021. PMID: 34256949. doi:10.1016/j.fertnstert.2021.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。